carbazilquinone has been researched along with Cholangioma in 1 studies
Carbazilquinone: An alkylating agent structurally similar to MITOMYCIN and found to be effective in the treatment of leukemia and various other neoplasms in mice. It causes leukemia and thrombocytopenia in almost all human patients.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tsushima, K | 1 |
| Sakata, Y | 1 |
| Shiratori, Y | 1 |
| Sakamoto, J | 1 |
| Koeda, J | 1 |
| Yamada, Y | 1 |
| Soma, N | 1 |
| Tamura, K | 1 |
| Yoshiwara, A | 1 |
| Soma, Y | 1 |
1 other study available for carbazilquinone and Cholangioma
| Article | Year |
|---|---|
[Cases of advanced cholangiocarcinoma showing partial response by the combination chemotherapy including protracted continuous infusion of 5-FU combined with intravenous administration of low-dose leucovorin and intra-arterial administration of MMC and CQ
Topics: Adenoma, Bile Duct; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Carbazilqui | 1991 |